Xcout Intel
Tempo Therapeutics
Tempo Therapeutics is an innovator in tissue engineering and regenerative medicine based in San Diego, California. The company secured Series A financing to advance its proprietary biomedical therapeutic products.
Subscribe to see Tempo Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Tempo Therapeutics at a glance
Tempo Therapeutics is a biotechnology company headquartered in United States. It has raised at least $34.2M across the 3 funding rounds on record. Its most recent funding round raised $14M in August 2026. Xcout tracks 15 named people at Tempo Therapeutics, including ERIC RICHMAN (CEO).
Tempo Therapeutics leadership
- ERIC RICHMANCEO
- Westbrook WeaverFounder & CEO
- Donald GriffinFounder & CSO
- Philip ScumpiaVP of Medical Affairs, Dermatology
- Stephanie DeshayesVP R&D
- ERIC RICHMANExecutive Officer
9 more named people on record for Tempo Therapeutics, with roles, board committees and tenure — see the full roster →
Tempo Therapeutics funding rounds
At least $34.2M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $14M | — | |
| Series A | $16.3M | 4 named | |
| SEC Form D filing | $3.8M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Tempo Therapeutics competitors
A few of Tempo Therapeutics's closest competitors — see the full list of competitors and alternatives →
MicroVascular Tissues, Inc. is a regenerative tissue company based in San Diego, California, developing medical products targeting microvascular conditions.
Frontier Bio develops engineered human tissues and vascular grafts to address cardiovascular disease and eliminate the need for organ donors and animal testing. The company provides tissue-engineered blood vessels for vascular grafts and commercializes human-based tissue models and services for preclinical testing.
Tiger BioSciences is a medical technology company that specializes in regenerative medicine, developing cellular, acellular, and matrix-like products for wound care and aesthetic treatments. The company also manages human tissue recovery programs to supply biological materials for clinical applications. It serves healthcare providers and medical professionals globally.
Truelastin Laboratories develops natural elastin biomaterials and product platforms for human health applications. The company serves the medical aesthetics and therapeutic sectors by creating tissue-engineered products and advanced drug delivery systems.
Get Tempo Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Tempo Therapeutics? Suggest a correction · Work at Tempo Therapeutics? Claim this profile
Is this your company? Add the Xcout Intel badge to your website
Free, for any company on Xcout Intel. It links visitors to this profile.
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Tempo Therapeutics in Xcout Intel
- 15 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access